Meeting Report: When clinical trials become too complex

After one volunteer died and four others were seriously injured during a clinical study in France in 2016, the European Medicines Agency revised its rules for first-in-human studies to tighten the requirements for the dosing of experimental drugs in humans. Introducing the changes in 2017, the agency said that clinical trial protocols are now more complex than ever before and sponsors will need to work harder to exercise oversight.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

Belgium